Prediction of Response to Antipsychotic Drugs in Schizophrenia Patients within the Early Phase of Treatment

Yildiz, MÜMİN; YAZICI, MÜMİN; YAGCIOGLU, A.; KARAHAN, SEVİLAY; SEVIK, Ali; GURSES, Nadide

doi:10.5455/bcp.20151128021707

Prediction of Response to Antipsychotic Drugs in Schizophrenia Patients within the Early Phase of Treatment

Yildiz M. K., YAZICI M. K., YAGCIOGLU A. E. A., KARAHAN S., SEVIK A. E., GURSES N.

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, cilt.25, sa.4, ss.390-398, 2015 (SCI-Expanded, Scopus, TRDizin)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 25 Sayı: 4
Basım Tarihi: 2015
Doi Numarası: 10.5455/bcp.20151128021707
Dergi Adı: KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.390-398
Hacettepe Üniversitesi Adresli: Evet

Özet

Objective: Currently, schizophrenia guidelines recommend waiting for 3 to 6 weeks before considering a patient as non-responder. However, recent studies indicate that the response to antipsychotic medications starts within the first two weeks of treatment. The aim of this study is to determine the predictive value of early improvement at 2 or 4 weeks for non-response at 6 weeks.